Upcoming milestones - Launch the Advangen range of hair loss prevention products - 4Q2010 - Complete veterinary cancer diagnostic trials ‐ 2Q2011 - Complete stages 3‐4 of AMI pre‐clinical trials in preparation for IND - 3Q2011 - Efficacy trials on single dose - Whole body retention studies - Complete stage 1 of CK3000 clinical trials (cancer screening) ‐ 3Q2011 - Completion of testing of the first 500 healthy and patient blood samples - Complete pre‐clinical studies for midkine hair growth product ‐ 4Q2011 - Long term safety - 28 day efficacy studies - Cancer diagnostic out‐licensing ‐ ongoing
Having just entered the 2nd quarter, I eagerly await results of the veterinary cancer diagnostic trials. Imagine having a test that could detect early cancer in your pets without incurring substantial vet costs. There's a lot happening and IMO this stock could take off again just on these results alone.
CDY Price at posting:
2.3¢ Sentiment: Buy Disclosure: Held
